Rubric Capital Management LP Ovid Therapeutics Inc. Transaction History
Rubric Capital Management LP
- $3.38 Billion
- Q2 2024
A detailed history of Rubric Capital Management LP transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Rubric Capital Management LP holds 5,315,969 shares of OVID stock, worth $6.27 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
5,315,969
Previous 5,315,969
-0.0%
Holding current value
$6.27 Million
Previous $16.2 Million
74.75%
% of portfolio
0.12%
Previous 0.55%
Shares
6 transactions
Others Institutions Holding OVID
# of Institutions
75Shares Held
39.2MCall Options Held
10.3KPut Options Held
200-
Madison Avenue Partners, LP New York, NY4.08MShares$4.82 Million0.53% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$4.71 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$4.55 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.09MShares$3.65 Million0.0% of portfolio
-
Artal Group S.A. Luxembourg, N42.5MShares$2.95 Million0.12% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $83.1M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...